Work

Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells

Year: 2015

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2015.04.028

Authors: Weilong Yao, Ping Yue, Guojing Zhang, Taofeek K. Owonikoko, Fadlo R. Khuri, Shi-Yong Sun

Institutions: Central South University, Emory University, Xiangya Hospital Central South University, Winship Cancer Institute

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Georgia Research Alliance, National Cancer Institute

Awards: Therapeutic potential of mTOR kinase inhibitors in lung cancer, Enhancing mTOR-targeted cancer therapy

OpenAlex ID: W2040959280

FWCI: 2.572

Cites: 32

Cited by: 51

Related to: 10